Advertisement

Topics

Nemaura Publishes Positive Data from SugarBEAT FDA Clinical Trial

12:47 EST 18 Dec 2018 | Investing News Network

Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, today published clinical data from its recently completed study intended to support a De Novo submission to the U.S Food & Drug Administration (“FDA”) for approval of its … Continued

The post Nemaura Publishes Positive Data from SugarBEAT FDA Clinical Trial appeared first on Investing News Network.

Original Article: Nemaura Publishes Positive Data from SugarBEAT FDA Clinical Trial

NEXT ARTICLE

More From BioPortfolio on "Nemaura Publishes Positive Data from SugarBEAT FDA Clinical Trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...